Dow Jones Futures: Stock Market Rally At Key Level As Coronavirus Cases Pick Up; Nvidia, PayPal, ServiceNow, Cloudflare, Biomarin Near Tight Entries; Analyzing TeslaInvestors Business Daily • 06/14/20
Wall Street's best-performing analysts like these 5 stocks right now - amid the market turmoilCNBC • 06/14/20
BioMarin Provides Highlights of 4 Years of Clinical Data from Ongoing Phase 1/2 Study of Valoctocogene Roxaparvovec Gene Therapy for Severe Hemophilia APRNewsWire • 05/31/20
BioMarin Announces Closing of Exercise by Initial Purchasers of Option to Purchase an Additional $50 million of 1.25% Senior Subordinated Convertible Notes due 2027PRNewsWire • 05/19/20
BioMarin Blows Past Q1 Estimates, Projects 1st Year of Profitability in 2020The Motley Fool • 04/30/20
BioMarin Pharmaceutical Inc. (BMRN) CEO Jean-Jacques Bienaimé on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 04/30/20
Biomarin Could Possibly Be The First To Obtain FDA Approval For Hemophilia Gene Therapy TreatmentSeeking Alpha • 04/15/20
Vertex Pharmaceuticals And BioMarin Pharmaceutical: 2 Safe Biotech Picks To Buy During This Bear MarketSeeking Alpha • 04/07/20
BioMarin (BMRN) Down 8% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 03/27/20
Why BioMarin Pharmaceutical, Bristol-Myers Squibb, and bluebird bio Are Getting Hammered MondayThe Motley Fool • 03/16/20